abstract |
A pharmaceutical formulation which comprises a parenterally acceptable carri er or diluent, estramustine phosphate and a sulfoalkyl ether cyclodextrin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation als o enables estramustine phosphate to be administered with no side effects at th e site of injection. |